Immatics (IMTX) Cash from Investing Activities (2019 - 2025)

Immatics (IMTX) reported Cash from Investing Activities of -$33.7 million for Q4 2025, up 33.55% on a YoY basis from -$25.2 million in Q4 2024, and down 123.48% sequentially from $143.4 million in Q3 2025.

Immatics (IMTX) Cash from Investing Activities (2019 - 2025) Analysis & Trends

Immatics (IMTX) has 7 years of Cash from Investing Activities data on file, last reported at -$33.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities rose 33.55% year-over-year to -$33.7 million; the trailing twelve-month figure through Dec 2025 stood at $231.7 million (up 240.78% YoY), and the FY2025 full-year result was $231.4 million, up 240.28% from the prior year.
  • Cash from Investing Activities retreated to -$33.7 million in Q4 2025, from $143.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $143.4 million in Q3 2025 to a low of -$262.7 million in Q1 2024.
  • A 5-year average of -$8.7 million and a median of -$3.0 million in 2023 frame the typical range for Cash from Investing Activities.
  • Peak annual rise in Cash from Investing Activities reached 510.15% in 2024, while the deepest fall reached 6481.11% in 2024.
  • Tracing IMTX's Cash from Investing Activities over 5 years: stood at -$2.1 million in 2021, then sank by 4300.84% to -$92.0 million in 2022, then jumped by 169.84% to $64.3 million in 2023, then sank by 178.82% to -$50.7 million in 2024, then jumped by 33.55% to -$33.7 million in 2025.
  • Business Quant data shows IMTX's Cash from Investing Activities at -$33.7 million in Q4 2025, $143.4 million in Q3 2025, and $72.7 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,200.25 Bn 66,199.96 Bn - -
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 471.75 Bn 466.96 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.94 Bn 114.69 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 69.87 Bn 61.12 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.43 Bn 62.43 Bn - -
8 Argenx Se 55.86 Bn 50.68 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn -25.54 Mn
10 Immatics 1.12 Bn 578.05 Mn - -33.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -33.66 Mn
Dec 31, 2025 -33.66 Mn
Sep 30, 2025 143.39 Mn
Sep 30, 2025 143.39 Mn
Jun 30, 2025 72.73 Mn
Jun 30, 2025 72.73 Mn
Mar 31, 2025 49.24 Mn
Mar 31, 2025 49.24 Mn
Dec 31, 2024 -50.66 Mn
Dec 31, 2024 -50.66 Mn
Sep 30, 2024 73.59 Mn
Sep 30, 2024 73.59 Mn
Jun 30, 2024 75.19 Mn
Jun 30, 2024 75.19 Mn
Mar 31, 2024 -262.70 Mn
Mar 31, 2024 -262.70 Mn
Dec 31, 2023 64.27 Mn
Dec 31, 2023 64.27 Mn
Sep 30, 2023 -76.82 Mn
Sep 30, 2023 -76.82 Mn